<DOC>
	<DOCNO>NCT00511914</DOCNO>
	<brief_summary>Annual trial registration sub-unit influenza vaccine produce mammalian cell culture , use strain composition 2007/2008 , administer adult elderly subject</brief_summary>
	<brief_title>Safety Immunogenicity Trivalent Subunit Influenza Vaccine Produced Mammalian Cell Culture Using Strain Composition 2007/2008</brief_title>
	<detailed_description />
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Subjects eligible enrollment study male female adult : 1 . ≥ 18 year age , mentally competent , willing able give inform consent prior study entry 2. available visit schedule study able comply study requirement 3. good health determine : medical history physical examination clinical judgment investigator Written inform consent obtain subject enrollment study nature study explain . Subjects enrol study least one follow criterion fulfil : 1 . Any serious chronic acute disease : 1 . Cancer ( leukemia , lymphoma , neoplasm ) , except benign localized skin cancer nonmetastatic prostate cancer presently treat chemotherapy 2 . Congestive heart failure 3 . Advanced arteriosclerotic disease 4 . Chronic obstructive pulmonary disease ( COPD ) require oxygen therapy and/or acute exacerbation COPD within last 14 day . 5 . Autoimmune disease ( include rheumatoid arthritis ) , immunosuppressive therapy ( see ) 6 . Insulin dependent diabetes mellitus 7 . Acute progressive hepatic disease 8 . Acute progressive renal disease 9 . Severe neurological psychiatric disorder 2 . History anaphylactic reaction and/or serious allergic reaction follow vaccination , proven hypersensitivity component study vaccine chemically related substance 3 . Known suspected ( high risk develop ) impairment/alteration immune function ( exclude normally associate advanced age ) result example : 1 . Receipt immunosuppressive therapy ( chronic therapy immunosuppressive drug , parenteral oral corticosteroid ( substitution dose case absence suprarenal function allow ) cancer chemotherapy/radiotherapy ) within last 2 month full length study , 2 . Receipt immunostimulants , 3 . Receipt parenteral immunoglobulin preparation , blood product , and/or plasma derivative within past 3 month full length study , 4 . Suspected known HIV infection HIVrelated disease . 4 . Known suspected history drug alcohol abuse 5 . Bleeding diathesis receive anticoagulant coumarin type 6 . Women pregnant woman childbearing potential unwilling practice acceptable contraception duration study ( 21 day ) 7 . Influenza immunization laboratory confirm influenza within last 6 month one influenza immunization within past 12 month 8 . Immunization vaccine and/or investigational vaccine four week prior study start 9 . Any significant acute chronic infection require systemic antibiotic treatment antiviral therapy within last 7 day 10 . Fever ( i.e . body temperature ≥ 38.0°C ) within past 3 day prior study entry 11 . Simultaneous participation another clinical study 12 . Any condition , , opinion investigator , might prevent subject participation interfere evaluation study objective .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>Influenza vaccine</keyword>
</DOC>